GEn1E Lifesciences
Developer of artificial intelligence-powered precision therapies designed to address immunology, inflammatory, rare, and oncologic diseases. The company offers a proprietary drug development model tha...
Valuation
$141M
Latest known
Share Price
N/A
Total Raised
$31.5M
Last Round
N/A